Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, North American Rheumatoid Arthritis Consortium Pen Genotyping Study Agreement

NEW YORK, Sept. 16 (GenomeWeb News) - Illumina signed an agreement to collaborate on a rheumatoid arthritis genotyping study with the North American Rheumatoid Arthritis Consortium, the company said today.


The study involves the analysis of 3,125 samples using Illumina's Linkage IV SNP panel with its BeadArray platform. NARAC researchers will analyze the data in hopes of identifying genes associated with rheumatoid arthritis, Illumina said. 


The effort is led by Peter Gregersen, director of the RobertS.BoasCenter for Genomics and Human Genetics at the Institute for Medical Research in Manhasset, NY. Gregersen is also the principal investigator of the Multiple Autoimmune Disease Genetics Consortium, an effort by the US National Institutes of Health effort to identify genes linked to autoimmune diseases.


The company declined to disclose financial details of the deal.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.